Long reads
for curious bodies.
Science, written like it's the first time someone explained it to you properly. Every piece reviewed by a physician on our team. No supplement affiliates, no clickbait, no algorithm chasing.
Everything, in order.
Testosterone isn't just for men. Here's why yours matters.
Low libido, flat mood, foggy thinking — the biomarker most physicians won't order for women.
Cortisol at 7am: what a morning cortisol tells you about your entire year
The single most predictive biomarker for burnout — and when to measure it.
The five labs every perimenopausal woman should run
Your TSH is almost never the whole story. Here's the full thyroid cascade.
Hashimoto's: the diagnosis 8 million women are missing
TPO antibodies can show up a decade before your TSH shifts. Catch it early.
AMH isn't a countdown clock
What your ovarian reserve test does — and doesn't — predict about your timeline.
Charting your cycle with data, not guesswork
Pairing basal body temperature with a four-point hormone panel.
Why 'normal' A1c is hiding your insulin resistance
Fasting insulin is the biomarker A1c misses by a decade.
The lipid panel your cardiologist wishes you'd asked for
ApoB, Lp(a), hs-CRP — the three markers that reframe heart risk for women.
Perimenopause is a 10-year runway, not a cliff
What's happening biologically from your late 30s onward — and how to track it.
HRT: reading the room on a decades-old debate
The 2023 Women's Health Initiative re-analysis, in plain language.
Ferritin, not hemoglobin — why iron deficiency hides from routine labs
The storage marker most GPs forget to order.
Vitamin D in February: an honest conversation
Why 40% of American women are deficient by late winter — and what to do about it.
Biological age vs. chronological age: what the epigenetic clock actually measures
DNAm methylation assays, interpreted without the hype.
Your cortisol curve is the map of your year
A four-point diurnal panel tells you more than any wearable.
The hormonal mimics of depression and anxiety
Thyroid, cortisol, and iron — three biomarkers worth ruling out before any prescription.
Brief: new evidence on perimenopause and LDL
A 2025 JAMA paper reframes cardiovascular screening for women in their 40s.
Brief: microbiome diversity and autoimmune risk
A prospective cohort links stool diversity scores to rheumatoid flags a decade out.
One long read.
Every Tuesday morning.
The Journal, in your inbox. Unsubscribe anytime, no dark patterns — and we never share your email with anyone.